Shu-ling Hou

Taiyuan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Alterations in Gut Microbiota and Metabolic Profiles in Relapsed or Refractory Lymphoma.

Alterations in Gut Microbiota and Metabolic Profiles in Relapsed or Refractory Lymphoma.

Journal: MicrobiologyOpen

Published: September 28, 2025

An Investigation Into the Clinical Characteristics and Management Strategies for Patients With Lymphoma and Concomitant COVID-19.

An Investigation Into the Clinical Characteristics and Management Strategies for Patients With Lymphoma and Concomitant COVID-19.

Journal: American journal of therapeutics

Published: January 07, 2025

A retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma.

A retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma.

Journal: Clinical neurology and neurosurgery

Published: February 22, 2024

Effect of P53 expression on double-expressor lymphoma and characteristics of DLBCL co-expressing P53 and MYC: Clinical, pathological, and biological insights.

Effect of P53 expression on double-expressor lymphoma and characteristics of DLBCL co-expressing P53 and MYC: Clinical, pathological, and biological insights.

Journal: Asian journal of surgery

Published: December 12, 2023

Research advances in exosomal microRNAs associated with drug resistance in diffuse large B-cell lymphoma.

Research advances in exosomal microRNAs associated with drug resistance in diffuse large B-cell lymphoma.

Journal: Asian journal of surgery

Published: May 19, 2023

Model for Predicting Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Discussion of Prophylaxis Measures.

Model for Predicting Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Discussion of Prophylaxis Measures.

Journal: World neurosurgery

Published: May 11, 2023

Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.

Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.

Journal: Asian journal of surgery

Published: October 21, 2022

Risk Factors Analysis of Thromboembolism in Patients with Lymphoma Chemotherapy

Risk Factors Analysis of Thromboembolism in Patients with Lymphoma Chemotherapy

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 06, 2022

Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse large B cell lymphoma.

Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse large B cell lymphoma.

Journal: Asian journal of surgery

Published: December 01, 2021

Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance.

Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: September 09, 2021

Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients.

Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients.

Journal: World journal of clinical cases

Published: August 18, 2021

Clinical Value of Serum Amyloid A and Misfolded Transthyretin for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

Clinical Value of Serum Amyloid A and Misfolded Transthyretin for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 07, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026